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Learning Objectives

Figure 1

Figure 3

• Identify the clinical and radiological findings
of Ewing-like sarcoma
• Review the importance of obtaining a
thorough history and physical exam, and
recognize their value in the process of
medical decision making
• Recognize that non-resolving pneumonia
may be the first manifestation of malignancy
involving the lung

Case Description
• A 14-year-old boy presented to the
emergency department after 3 days of fever,
pleurisy, and worsening left mid-back pain.
Chest x-ray (CXR) showed left lower lobe
(LLL) airspace opacity consistent with
pneumonia without evidence of effusion. He
was admitted for IV antibiotics and
discharged 6 hours later with oral antibiotics.
• Two weeks later he presented to his primary
care physician with continued pain. Repeat
CXR showed LLL pneumonia with effusion.
Figure 1. Patient was then directly admitted
after failed outpatient treatment for
pneumonia with effusion.
• Further history and physical exam unveiled
an unintentional 20 lb weight loss over the
course of 6 months, as well as a mass
protruding between his posterior ribs.
• Lack of response to antibiotics prompted
testing with computer tomography (CT) of
the chest, which showed a large
heterogeneous mass at the posterior left
upper quadrant (LUQ) of the abdomen
protruding through the posterior aspect of
the left hemidiaphragm causing atelectasis.
Figure 2.

Figure 1: PA/Lateral CXR. LLL pneumonia with left pleural effusion.

• Magnetic resonance imaging (MRI)
demonstrated a 17.9 x 10.6 cm
heterogeneous hyperenhancing
hypervascular posterior LUQ mass which
invades the posterior wall of the thorax and
abuts if not invades the left
hemidiaphragm. Figure 3.
• A biopsy was performed, which revealed
this mass to be an Ewing-like sarcoma with
a BCOR-CCNB3 rearrangement.
• Patient was treated with chemotherapy
prior to surgical resection and radiation.

Figure 2

Figure 2: CT chest with contrast. Large LUQ mass causing atelectasis.

Figure 3: MRI of the chest. Mass invades the posterior aspect of
the chest wall and displaces the left kidney and spleen anteriorly.

Discussion
• Broad differential diagnoses apply to nonresolving pneumonia. These include
infectious, inflammatory or neoplastic
processes.
• Neoplasms may be associated with nonresolving pneumonia either by compromise
of the airway lumen and secondary
postobstructive pneumonia or by mimicking
an infiltrative process.
• Ewing-like sarcomas (ELS) are a rare
heterogenous group of round cell sarcomas
that typically occur in the bone and soft
tissue of pediatric and young adult patients.
• ELS share various degrees of
morphological, molecular, and clinical
similarity with Ewing sarcomas. However,
these tumors lack the pathognomonic
molecular hallmark of Ewing sarcoma, which
is defined as translocation between a gene
of the RNA-binding TET family with a gene
of the ETS-transcription family.

• Accurate classification and distinction from
classical Ewing sarcomas is important for
patient management.
• The diagnosis is suggested based on a
combination of morphologic and
immunophenotypic features, but requires
molecular testing for confirmation.
• A subset of ELS harboring the BCORCCNB3 rearrangement have been
described recently.
• BCOR-rearranged sarcomas most
commonly arise in bones of patients in their
second decade (with a median age of 15
years).
• There is a striking male predominance, with
nearly 85% of BCOR-rearranged sarcoma
cases occurring in males.
• The 5-year overall survival for BCORrearranged sarcomas is approximately 75%.
• BCOR-rearranged sarcomas located in the
axial skeleton and soft tissues show a
significantly shorter survival.
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